| Quantity | 20 nmol, 50 nmol, 100 nmol, 200 nmol | 5 slides | 2 vials | Inquire | 20 nmol, 50 nmol, 100 nmol, 200 nmol |
| Description | The product SIRGT92208WQ-2F is a type of small interfering RNA (siRNA) that targets Dhx33 gene and regulates the expression of gene. The siRNA interferes with the expression of Dhx33 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNAThe product SIRGT92208WQ-2F is a type of small interfering RNA (siRNA) that targets Dhx33 gene and regulates the expression of gene. The siRNA interferes with the expression of Dhx33 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2_-deoxy-2_-fluoro (2'-F) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More | Creative Biolabs' Neuropathy Frozen Tissue Panels are designed for the study of Alzheimer's disease, Parkinson's disease, dementia, multiple sclerosis, progressive supranuclear palsy (PSP) and depression. | Creative Biolabs offers the overexpression cell line which expressing the co-inhibitory and co-stimulatory immune checkpoints of human, mouse and cynomolgus monkey origin to accelerate immunotherapy discovery and development. | This product is a 420.7 kDa native Cynomolgus Monkey C1q protein isolated from normal Cynomolgus Monkey serum. It is availible for ELISA. | The product SIRGT99541WQ-LNA is a type of small interfering RNA (siRNA) that targets A2m gene and regulates the expression of gene. The siRNA interferes with the expression of A2m gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA isThe product SIRGT99541WQ-LNA is a type of small interfering RNA (siRNA) that targets A2m gene and regulates the expression of gene. The siRNA interferes with the expression of A2m gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More |